3/A

FORM 3/A SUBMISSION

Company: Apellis Pharmaceuticals, Inc.
Filed: February 5, 2020
Period of Report: November 8, 2017
Accession Number: 0000899243-20-003295

View Document ↗ View on SEC.gov ↗